Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.02 USD
Change Today -0.05 / -0.82%
Volume 206.6K
As of 8:10 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Edwin F. Weidig III

Principal Accounting Officer and Director of Finance, Neogenomics Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

45--

Background*

Mr. Edwin F. Weidig, III has been Principal Accounting Officer and Director of Finance at Neogenomics Inc. since January 2012. Mr. Weidig has served as Corporate Controller at Neogenomics Inc. since joining it in October 2007. From May 2005 to October 2007, he served as a Division Controller for Meritage Homes Corporation in Fort Myers, Florida, and from January 1999 to May 2005, he served in public accounting for a local firm in Fort Myers Florida and for the PricewaterhouseCoopers ...

Read Full Background

Corporate Headquarters*

12701 Commonwealth Drive
Fort Myers, Florida 33913

United States

Phone: 239-768-0600
Fax: 239-690-4237

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BSBA 1999
Merrimack College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEO:US $6.02 USD -0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Elazar Rabbani Ph.D.Co-Founder, Chairman, Chief Executive Officer and Secretary
Enzo Biochem Inc.
$555.5K
Raymond C. Kubacki Jr.Chairman, Chief Executive Officer and President
Psychemedics Corp.
$536.9K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$767.9K
Panna Sharma Chief Executive Officer, President and Director
Cancer Genetics, Inc.
$600.0K
Michael J. Pellini M.D., MBAChief Executive Officer and Director
Foundation Medicine, Inc.
$416.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGENOMICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.